PGT-A Overuse And Misinformation In Reproductive Medicine, According To Dr. Norbert Gleicher

Dr. Norbert Gleicher breaks down why he believes PGT- A is overused, over-funded, and over-aggrandized on the latest episode of Inside Reproductive Health with Griffin Jones. Is the genetics testing industry the new “big pharma”? Could PGT-A be harming pregnancy chances instead of improving them? And if so, why isn’t anyone talking about it? Tune in to see where you land on this week’s topic. Listen to hear: Grif and Dr. Gleicher talk about IVF “add-ons”. Discussion on the huge differences in practice patterns. The failures at the early attempts of rolling up IVF centers in the 1990s. Talking points on the efficacy, or lack thereof, of PGT. Gleicher’s stance on scientific literature’s inability to support the use of PGT to the level it is being used. Gleicher explain why he believes Big Pharma has been replaced by the genetic testing companies, who also happen to be the biggest benefactors of PGT.